# Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clazosentan-an-endothelin-receptor-antagonist-in-patients-with-aneurysmal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | R. Loch Macdonald,Randall T. Higashida,E. Keller,Stephan A. Mayer,Andy Molyneux,Andreas Raabe,Peter Vajkoczy,Isabel Wanke,Doris Bach,Aline Frey,Angelina Marr,Sébastiên Roux,Neal F. Kassell |
| Citations | 641 |
| DOI | 10.1016/s1474-4422(11)70108-9 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2102182787 |
| PMID | 21640651 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Peter Vajkoczy](https://scholariq.org/researchers/peter-vajkoczy/)

## Paper primary topic

- [Intracranial Aneurysms: Treatment and Complications](https://scholariq.org/topics/intracranial-aneurysms-treatment-and-complications/)

## Paper topics

- [Intracranial Aneurysms: Treatment and Complications](https://scholariq.org/topics/intracranial-aneurysms-treatment-and-complications/)
- [Intracerebral and Subarachnoid Hemorrhage Research](https://scholariq.org/topics/intracerebral-and-subarachnoid-hemorrhage-research/)
- [Takotsubo Cardiomyopathy and Associated Phenomena](https://scholariq.org/topics/takotsubo-cardiomyopathy-and-associated-phenomena/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.